18 results on '"Kindscher JD"'
Search Results
2. Correspondence
- Author
-
Kindscher Jd
- Subjects
Excess mortality ,medicine.medical_specialty ,business.industry ,Trauma center ,Emergency Medicine ,medicine ,Emergency Nursing ,Cardiology and Cardiovascular Medicine ,Intensive care medicine ,business ,Rapid infusion - Published
- 1997
3. Bioelectrical impedance in the clinical evaluation of liver disease
- Author
-
Schloerb, PR, primary, Forster, J, additional, Delcore, R, additional, and Kindscher, JD, additional
- Published
- 1996
- Full Text
- View/download PDF
4. Fluid Management During Kidney Transplantation: A Consensus Statement of the Committee on Transplant Anesthesia of the American Society of Anesthesiologists.
- Author
-
Wagener G, Bezinover D, Wang C, Kroepfl E, Diaz G, Giordano C, West J, Kindscher JD, Moguilevitch M, Nicolau-Raducu R, Planinsic RM, Rosenfeld DM, Lindberg S, Schumann R, and Pivalizza EG
- Subjects
- Central Venous Pressure, Colloids administration & dosage, Consensus, Crystalloid Solutions administration & dosage, Fluid Therapy adverse effects, Humans, Societies, Medical, Anesthesiologists, Fluid Therapy methods, Kidney Transplantation
- Abstract
Background: Intraoperative fluid management may affect the outcome after kidney transplantation. However, the amount and type of fluid administered, and monitoring techniques vary greatly between institutions and there are limited prospective randomized trials and meta-analyses to guide fluid management in kidney transplant recipients., Methods: Members of the American Society of Anesthesiologists (ASA) committee on transplantation reviewed the current literature on the amount and type of fluids (albumin, starches, 0.9% saline, and balanced crystalloid solutions) administered and the different monitors used to assess fluid status, resulting in this consensus statement with recommendations based on the best available evidence., Results: Review of the current literature suggests that starch solutions are associated with increased risk of renal injury in randomized trials and should be avoided in kidney donors and recipients. There is no evidence supporting the routine use of albumin solutions in kidney transplants. Balanced crystalloid solutions such as Lactated Ringer are associated with less acidosis and may lead to less hyperkalemia than 0.9% saline solutions. Central venous pressure is only weakly supported as a tool to assess fluid status., Conclusions: These recommendations may be useful to anesthesiologists making fluid management decisions during kidney transplantation and facilitate future research on this topic., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
5. Intraoperative Cardiac Arrest During Adult Liver Transplantation: Incidence and Risk Factor Analysis From 7 Academic Centers in the United States.
- Author
-
Smith NK, Zerillo J, Kim SJ, Efune GE, Wang C, Pai SL, Chadha R, Kor TM, Wetzel DR, Hall MA, Burton KK, Fukazawa K, Hill B, Spad MA, Wax DB, Lin HM, Liu X, Odeh J, Torsher L, Kindscher JD, Mandell MS, Sakai T, and DeMaria S Jr
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Incidence, Liver Transplantation adverse effects, Male, Middle Aged, Mortality trends, Retrospective Studies, Risk Factors, United States epidemiology, Young Adult, Academic Medical Centers trends, Heart Arrest etiology, Heart Arrest mortality, Intraoperative Complications etiology, Intraoperative Complications mortality, Liver Transplantation mortality
- Abstract
Background: Intraoperative cardiac arrest (ICA) has a reported frequency of 1 in 10,000 anesthetics but has a much higher estimated incidence in orthotopic liver transplantation (OLT). Single-center studies of ICA in OLT are limited by small sample size that prohibits multivariable regression analysis of risks., Methods: Utilizing data from 7 academic medical centers, we performed a retrospective, observational study of 5296 adult liver transplant recipients (18-80 years old) between 2000 and 2017 to identify the rate of ICA, associated risk factors, and outcomes., Results: ICA occurred in 196 cases (3.7% 95% confidence interval [CI], 3.2-4.2) and mortality occurred in 62 patients (1.2%). The intraoperative mortality rate was 31.6% in patients who experienced ICA. In a multivariable generalized linear mixed model, ICA was associated with body mass index (BMI) <20 (odds ratio [OR]: 2.04, 95% CI, 1.05-3.98; P = .0386), BMI ≥40 (2.16 [1.12-4.19]; P = .022), Model for End-Stage Liver Disease (MELD) score: (MELD 30-39: 1.75 [1.09-2.79], P = .02; MELD ≥40: 2.73 [1.53-4.85], P = .001), postreperfusion syndrome (PRS) (3.83 [2.75-5.34], P < .001), living donors (2.13 [1.16-3.89], P = .014), and reoperation (1.87 [1.13-3.11], P = .015). Overall 30-day and 1-year mortality were 4.18% and 11.0%, respectively. After ICA, 30-day and 1-year mortality were 43.9% and 52%, respectively, compared to 2.6% and 9.3% without ICA., Conclusions: We established a 3.7% incidence of ICA and a 1.2% incidence of intraoperative mortality in liver transplantation and confirmed previously identified risk factors for ICA including BMI, MELD score, PRS, and reoperation and identified new risk factors including living donor and length of surgery in this multicenter retrospective cohort. ICA, while rare, is associated with high intraoperative mortality, and future research must focus on therapy to reduce the incidence of ICA.
- Published
- 2021
- Full Text
- View/download PDF
6. Bacchus Listed for a Liver Transplant: Comment.
- Author
-
Bezinover D, Diaz G, Duggan E, Galusca D, Kindscher JD, Moguilevitch M, Nicolau-Raducu R, Pivalizza EG, Planinsic R, Ramsay MAE, Rosenfeld DM, Skubas N, and Wagener G
- Subjects
- Humans, Risk Factors, Tissue Donors, Liver Transplantation
- Published
- 2020
- Full Text
- View/download PDF
7. Anesthesia-related cardiac arrest.
- Author
-
Ellis SJ, Newland MC, Simonson JA, Peters KR, Romberger DJ, Mercer DW, Tinker JH, Harter RL, Kindscher JD, Qiu F, and Lisco SJ
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Causality, Child, Child, Preschool, Databases, Factual statistics & numerical data, Female, Heart Arrest etiology, Hospital Mortality, Humans, Incidence, Infant, Male, Middle Aged, Sex Distribution, Surveys and Questionnaires, United States epidemiology, Young Adult, Anesthesia adverse effects, Anesthesia statistics & numerical data, Heart Arrest epidemiology
- Abstract
Background: Much is still unknown about the actual incidence of anesthesia-related cardiac arrest in the United States., Methods: The authors identified all of the cases of cardiac arrest from their quality improvement database from 1999 to 2009 and submitted them for review by an independent study commission to give them the best estimate of anesthesia-related cardiac arrest at their institution. One hundred sixty perioperative cardiac arrests within 24 h of surgery were identified from an anesthesia database of 217,365 anesthetics. An independent study commission reviewed all case abstracts to determine which cardiac arrests were anesthesia-attributable or anesthesia-contributory. Anesthesia-attributable cardiac arrests were those cases in which anesthesia was determined to be the primary cause of cardiac arrest. Anesthesia-contributory cardiac arrests were those cases where anesthesia was determined to have contributed to the cardiac arrest., Results: Fourteen cardiac arrests were anesthesia-attributable, resulting in an incidence of 0.6 per 10,000 anesthetics (95% CI, 0.4 to 1.1). Twenty-three cardiac arrests were found to be anesthesia-contributory resulting in an incidence of 1.1 per 10,000 anesthetics (95% CI, 0.7 to 1.6). Sixty-four percent of anesthesia-attributable cardiac arrests were caused by airway complications that occurred primarily with induction, emergence, or in the postanesthesia care unit, and mortality was 29%. Anesthesia-contributory cardiac arrest occurred during all phases of the anesthesia, and mortality was 70%., Conclusion: As judged by an independent study commission, anesthesia-related cardiac arrest occurred in 37 of 160 cardiac arrests within the 24-h perioperative period.
- Published
- 2014
- Full Text
- View/download PDF
8. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial.
- Author
-
Sprung J, Kindscher JD, Wahr JA, Levy JH, Monk TG, Moritz MW, and O'Hara PJ
- Subjects
- Adolescent, Adult, Aged, Antibodies analysis, Blood Chemical Analysis, Blood Pressure, Blood Substitutes adverse effects, Blood Transfusion, Female, Heart Rate, Humans, Immunoglobulin G analysis, Infusions, Intravenous, Intraoperative Period, Isotonic Solutions administration & dosage, Male, Methemoglobin analysis, Middle Aged, Ringer's Lactate, Single-Blind Method, Blood Loss, Surgical, Blood Substitutes administration & dosage, Hemoglobins analysis, Intraoperative Complications therapy
- Abstract
Unlabelled: Hemoglobin-based oxygen carrier-201 (HBOC-201, hemoglobin glutamer-250 [bovine], Hemopure; Biopure Corporation, Cambridge, MA) is polymerized hemoglobin of bovine origin being developed as an oxygen therapeutic. In this study, we evaluated the tolerability of a single intraoperative dose of HBOC-201 in surgical patients. In a single-blinded, multicenter study, 81 patients were randomized to receive either a single infusion of HBOC-201 (55 patients) or an equivalent volume of lactated Ringer's solution (26 patients). Forty-two patients originally assigned to the HBOC-201 group received the entire planned treatment of only one of the following doses: 0.6, 0.9, 1.2, 1.5, 2.0, or 2.5 g/kg of body weight. Thirteen of the 55 patients in the HBOC-201-assigned group did not reach the trigger point for transfusion administration, and they were not included in the analysis. We studied clinical outcomes and compared hematologic findings, blood chemistry values, and blood use in the two treatment groups. There were no patient deaths in this study. No pattern of clinically significant laboratory abnormalities could be attributed to exposure to HBOC-201. In the HBOC-201 group, 2 patients had a transient increased concentration of serum transaminases and 6 had transient skin discoloration. One patient in the HBOC-201 group had mast cell degranulation with hypotension. Postoperatively, methemoglobin plasma concentrations increased in the HBOC-201 group in a dose-dependent manner, reaching maximal values of 3.7% +/- 3.2% (average of all doses given) on postoperative day 3. There was no difference in the mean number of allogeneic blood units transfused in the 2 groups (3.3 +/- 1.8 and 3.7 +/- 4.1 for the lactated Ringer's solution and HBOC-201 groups, respectively) over the course of hospitalization. The intraoperative administration of HBOC-201, up to a maximum of 245 g, was generally well tolerated. There was no relationship between HBOC-201 use and the number of allogeneic blood units transfused over the entire hospitalization course. The administration of HBOC-201 was associated with a delayed (third postoperative day) dose-dependent increase in the plasma methemoglobin concentration. We conclude that the intraoperative use of HBOC-201 was generally well tolerated., Implications: The intraoperative use of hemoglobin glutamer-250 (bovine) (HBOC-201, Hemopure was generally well tolerated. The administration of HBOC-201 was associated with a delayed increase in the plasma methemoglobin concentrations.
- Published
- 2002
- Full Text
- View/download PDF
9. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
- Author
-
Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, and Goto H
- Subjects
- Animals, Depression, Chemical, Dose-Response Relationship, Drug, Male, Rabbits, Adrenergic beta-Antagonists pharmacology, Blood Pressure drug effects, Heart Rate drug effects, Morpholines pharmacology, Propanolamines pharmacology, Urea analogs & derivatives, Urea pharmacology
- Abstract
Purpose: To compare the cardiovascular and sympathetic effects of a new ultra-short-acting, highly cardioselective beta- blocker, landiolol, with esmolol, using an in vivo rabbit model., Methods: Different bolus doses of landiolol (0.3, 1.0, 3.0 and 10.0 mg*kg(-1)) or esmolol (0.5, 1.5 and 5.0 mg*kg(-1)) were given intravenously, and the effects on heart rate (HR) mean arterial pressure (MAP) and renal sympathetic nerve activity (RSNA) were compared., Results: Both landiolol and esmolol produced a dose-dependent decrease in HR. The maximum percent reductions of HR were similar with landiolol 3 mg*kg(-1) and esmolol 5 mg*kg(-1) (-14.0 +/- 0.9% and -13.9 +/- 1.4%, mean +/- SE, respectively). HR decreased more rapidly with landiolol than with esmolol. Esmolol produced a dose-dependent decrease in MAP that was not observed with landiolol. The percent maximum reduction of MAP was -38.2 +/- 3.2% with esmolol 5 mg*kg(-1). RSNA increased in a dose-dependent fashion with esmolol, but no changes were noted with landiolol., Conclusion: These results suggest that, in rabbits, landiolol has slightly more potent negative chronotropic action than esmolol with significantly less effects on blood pressure.
- Published
- 2001
- Full Text
- View/download PDF
10. Hemodynamic and sympathetic effects of fenoldopam and sodium nitroprusside.
- Author
-
Yakazu Y, Iwasawa K, Narita H, Kindscher JD, Benson KT, and Goto H
- Subjects
- Animals, Baroreflex drug effects, Blood Pressure drug effects, Denervation, Heart Rate drug effects, Kidney drug effects, Kidney innervation, Rabbits, Antihypertensive Agents pharmacology, Dopamine Agonists pharmacology, Fenoldopam pharmacology, Hemodynamics drug effects, Nitroprusside pharmacology, Sympathetic Nervous System drug effects
- Abstract
Background: Fenoldopam is a novel dopamine-1 receptor selective agonist that can be used as a vasodilator perioperatively to treat hypertension and to produce induced hypotension. We were interested to find out whether there were any differences between fenoldopam (FM) and sodium nitroprusside (SNP), one of the most popular vasodilators, in their effects on hemodynamics and sympathetic outflow using not only neuraxis intact but also baro-denervated animal models., Methods: A total of 60 New Zealand white rabbits were divided into two groups of 30 each: the neuraxis-intact group and the totally baro-denervated group. Each group was further divided into three groups of 10 each to receive SNP 10 microg x kg(-1), FM 10 microg x kg(-1) or FM 20 microg x kg(-1), respectively. Mean arterial pressure (MAP), heart rate (HR) and renal sympathetic nerve activity (RSNA) were recorded before and after intravenous (i.v.) administration of each agent. In addition, cardiac and sympathetic baroreflex sensitivity were assessed in the neuraxis-intact animals., Results: In the neuraxis-intact groups, although RSNA was increased to a similar extent in all three groups (P<0.01), the reduction of MAP with FM groups was significantly greater than with SNP (P<0.05). HR was increased only in the SNP group. Cardiac (HR) and sympathetic barosensitivity were significantly attenuated with FM 20 microg x kg(-1) as compared to the SNP group. In the baro-denervated groups, there were significant and similar degrees of reduction of MAP in all three group up to 1 min (P<0.01). MAP remained significantly decreased in the FM groups for 10 min (only 2 min with SNP) in both animal models., Conclusions: Unlike sodium nitroprusside, fenoldopam attenuates both cardiac (heart rate) and sympathetic baroreflex sensitivity, which may explain the lack of rebound hypertension with fenoldopam. The offset of hypotensive effects of fenoldopam is a significantly slower process as compared to nitroprusside, and this may be an unfavorable feature of fenoldopam should overshoot of hypotension occur.
- Published
- 2001
- Full Text
- View/download PDF
11. Anesthetic induction agents, sympathetic nerve activity and baroreflex sensitivity: a study in rabbits comparing thiopental, propofol and etomidate.
- Author
-
Aono H, Hirakawa M, Unruh GK, Kindscher JD, and Goto H
- Subjects
- Animals, Blood Pressure drug effects, Heart Rate drug effects, Rabbits, Anesthetics, Intravenous pharmacology, Baroreflex drug effects, Etomidate pharmacology, Propofol pharmacology, Sympathetic Nervous System drug effects, Thiopental pharmacology
- Abstract
The mechanisms of arterial hypotension following intravenous anesthetic induction agents are multifactorial. The purpose of this study was to evaluate and compare the effects of thiopental, propofol and etomidate on hemodynamics, sympathetic outflow and arterial baroreflex sensitivity using not only neuraxis-intact but also totally baro-denervated rabbits. A total of 60 rabbits was anesthetized with urethane, tracheotomized, and mechanically ventilated with oxygen in nitrogen (FiO2 0.5). The left renal sympathetic nerve was isolated and placed on a bipolar electrode to record renal sympathetic nerve activity (RSNA). Thirty animals underwent a surgical preparation of total baroreceptor denervation. Bolus injections of an anesthesia induction dose of thiopental 4 mg/kg and twice the induction dose of propofol 4 mg/kg significantly decreased RSNA to the same extent (19.4+/-6.7 and 19.7+/-5.2% reduction, mean +/- SEM) and mean arterial pressure (MAP) also to the same extent (19.5+/-4.6 and 22.1+/-3.1% reduction) in the neuraxis-intact animals. RSNA was increased (34.5+/-6%) without reduction of MAP by an induction dose of etomidate, 0.3 mg/kg. Sympathetic barosensitivity was attenuated even 10 min after thiopental at 4 mg/kg or propofol at 4 mg/kg (68% and 54% of control, respectively). Propofol at 2 mg/kg (induction dose) and etomidate at 0.6 mg/kg decreased RSNA and MAP only in the baro-denervated animals. It was found from the barosensitivity study that patients can be hemodynamically unstable even though blood pressure has returned to normal after thiopental and propofol administration. Data suggest that etomidate can even stimulate the sympathetic nervous system and increase sympathetic outflow. It was also clearly found from the baro-denervated animal study that thiopental was stronger than propofol in directly suppressing sympathetic outflow at the induction dose.
- Published
- 2001
- Full Text
- View/download PDF
12. Suppressive effects of remifentanil on hemodynamics in baro-denervated rabbits.
- Author
-
Shinohara K, Aono H, Unruh GK, Kindscher JD, and Goto H
- Subjects
- Animals, Baroreflex drug effects, Blood Pressure drug effects, Denervation, Heart Rate drug effects, Naloxone pharmacology, Narcotic Antagonists pharmacology, Rabbits, Remifentanil, Sympathetic Nervous System drug effects, Analgesics, Opioid therapeutic use, Hemodynamics drug effects, Piperidines therapeutic use, Pressoreceptors physiology
- Abstract
Purpose: To elucidate mechanisms by which remifentanil, an ultra-short-acting mu-opioid receptor agonist, causes hypotension and bradycardia., Methods: Mean arterial pressure (MAP), heart rate (HR) and renal sympathetic nerve activity (RSNA) were measured and recorded after bolus injections of 1, 2 or 5 microg x kg(-1) of remifentanil in neuraxis intact (n=6 for each dose) and baro-denervated rabbits (n=6 for each dose). Arterial baroreflex sensitivity was assessed by depressor tests. An additional six baro-denervated animals received remifentanil, 5 microg x kg(-1) after pretreatment with naloxone, 40 microg x kg(-1)., Results: All values were expressed in % change from baseline. In the neuraxis intact animals, MAP and HR were decreased briefly immediately after remifentanil injection. RSNA was increased dose-dependently: 137 +/- 8% (mean +/- SE), 170 +/- 14% (P < 0.05) and 225 +/- 29% (P < 0.05) after 1, 2 and 5 microg x kg(-1) remifentanil, respectively. RSNA was increased even after MAP and HR had returned to baseline values. The depressor tests revealed that remifentanil did not attenuate arterial baroreflex sensitivity. In the baro-denervated animals, MAP and HR decreased gradually to 77 +/- 3% (P < 0.05) and 94 +/- 1% (P < 0.05), respectively 300 sec after 5 microg x kg(-1) remifentanil. At that time, increased RSNA (159 +/- 9%, P < 0.05) had returned to baseline. Pretreatment with naloxone in the baro-denervated animals abolished these changes., Conclusion: Remifentanil decreases HR and MAP by its central vagotonic effect and by stimulating peripheral mu-opioid receptors. These effects appear to be counteracted and masked by its central sympathotonic effect and by maintaining arterial baroreflex integrity.
- Published
- 2000
- Full Text
- View/download PDF
13. Abdominal wall lift versus carbon dioxide insufflation for laparoscopic resection of ovarian tumors.
- Author
-
Ogihara Y, Isshiki A, Kindscher JD, and Goto H
- Subjects
- Abdominal Muscles, Acid-Base Equilibrium, Adult, Blood Glucose analysis, Blood Pressure, Carbon Dioxide, Female, Humans, Lung physiopathology, Prospective Studies, Laparoscopy, Ovarian Neoplasms surgery, Pneumoperitoneum, Artificial
- Abstract
Study Objective: To evaluate and compare changes in pulmonary mechanics and stress hormone responses between abdominal wall lift (gasless) and carbon dioxide (CO2) insufflation laparoscopic surgery during controlled general anesthesia., Design: Prospective, randomized clinical study., Setting: Operating rooms at a university medical center., Patients: 12 ASA physical status I and II female patients undergoing laparoscopic resection of ovarian tumors., Interventions: Patients were divided into two groups of six each: the abdominal wall lift group and the CO2 pneumoperitoneum laparoscopic group. Following induction of anesthesia, patients were paralyzed and the trachea was intubated. Anesthesia was maintained with isoflurane and nitrous oxide (N2O) in oxygen. Throughout the procedure, patients were mechanically ventilated with a tidal volume of 10 ml/kg and a respiratory rate of 10 breaths per minute., Measurements and Main Results: During the laparoscopic procedure, arterial blood gases, acid-base balance, pulmonary mechanics, stress-related hormones, and urine output were measured and recorded. In the CO2 pneumoperitoneum group, arterial CO2 tension increased (p < 0.01), dynamic pulmonary compliance decreased (p < 0.01), peak inspiratory airway pressure increased (p < 0.01), and plasma epinephrine (p < 0.05), norepinephrine (p < 0.05), dopamine (p < 0.01), and antidiuretic hormones (p < 0.05) increased significantly during the laparoscopic procedure as compared to the abdominal lift group. Adrenocorticotropic hormone and cortisol increased as compared to baseline value in both groups (p < 0.05). Urine output was significantly less (p < 0.01) in the CO2 pneumoperitoneum group than in the abdominal wall lift group., Conclusions: Abdominal wall lift laparoscopic surgery is physiologically superior to CO2 pneumoperitoneum laparoscopic surgery as seen during the conditions of this study. Abdominal wall lift laparoscopic surgery provides normal acid-base balance and a lesser degree of hormonal stress responses, it maintains urine output, and it avoids derangement of pulmonary mechanics.
- Published
- 1999
- Full Text
- View/download PDF
14. Excess mortality associated with the use of rapid infusion system at level 1 trauma center.
- Author
-
Kindscher JD
- Subjects
- Bias, Controlled Clinical Trials as Topic methods, Critical Care, Fluid Therapy adverse effects, Fluid Therapy methods, Humans, Kansas, Patient Care Team, Patient Selection, Reproducibility of Results, Retrospective Studies, Survival Rate, Trauma Centers organization & administration, Wounds and Injuries epidemiology, Wounds and Injuries mortality, Fluid Therapy mortality, Infusion Pumps adverse effects, Wounds and Injuries therapy
- Published
- 1997
- Full Text
- View/download PDF
15. Is the role of transjugular intrahepatic portosystemic shunts limited in the management of patients with end-stage liver disease?
- Author
-
Forster J, Siegel EL, Delcore R, Payne KM, Laurin J, and Kindscher JD
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies, Hypertension, Portal complications, Hypertension, Portal surgery, Liver Diseases etiology, Liver Diseases surgery, Portasystemic Shunt, Transjugular Intrahepatic
- Abstract
Background: Transjugular intrahepatic portosystemic shunts (TIPS) are an established method for the treatment of the complications of portal hypertension. Recent reports have suggested that TIPS require frequent follow-up and may interfere with orthotopic liver transplantation (OLT)., Methods: Retrospective chart review was performed of ultrasound studies, angiographic studies, and complications of the first 100 patients treated consecutively with TIPS from February 1992 through October 1995., Results: Ninety-seven patients had functional TIPS. Thirty-one percent of patients treated emergently survived, significantly less than the 96% survival of elective patients. Fifty percent of the shunts were found to require angioplasty by 5 months. Seventeen patients treated with OLT did well, without intraoperative bleeding problems, and are alive., Conclusions: The TIPS method treats successfully the complications of portal hypertension but requires careful follow-up. The technique may be used prior to OLT. For non-OLT candidates, the cost effectiveness of TIPS versus surgical shunting remains in question.
- Published
- 1996
- Full Text
- View/download PDF
16. Liver transplantation in a patient with sickle cell anemia.
- Author
-
Kindscher JD, Laurin J, Delcore R, and Forster J
- Subjects
- Anemia, Sickle Cell complications, Female, Hepatitis C complications, Hepatitis C surgery, Humans, Middle Aged, Anemia, Sickle Cell physiopathology, Liver Transplantation
- Abstract
Orthotopic liver transplantation in a patient with sickle cell disease presents many new challenges to the transplant team. We describe the case of a 47-year-old patient with sickle cell disease and hepatitis C virus-induced cirrhosis who required liver transplantation.
- Published
- 1995
- Full Text
- View/download PDF
17. Cardiac failure after orthotopic liver transplantation.
- Author
-
Levine JM and Kindscher JD
- Subjects
- Adult, Humans, Male, Cardiac Output, Low etiology, Intraoperative Complications, Liver Transplantation adverse effects
- Published
- 1994
- Full Text
- View/download PDF
18. The anesthetic management of liver transplantation.
- Author
-
Kindscher JD and Levine JM
- Subjects
- Female, Humans, Male, Anesthesia, Liver Transplantation
- Published
- 1993
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.